Skip to content

To assess the postoperative outcomes after implementation of the protocol in patients undergoing surgery for gynaecological malignancies in the COVID-19 pandemic

Covid ERAS-Effect of implementation of the Enhanced Recovery After Surgery (ERAS) protocol on patients undergoing surgery for gynaecological malignancy during the COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025634
Enrollment
40
Registered
2020-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

None listed

Sponsors

Dr Kanika Batra Modi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with an ovarian/fallopian tube/peritoneal cancer of any histology (collectively referred to as ovarian cancer), endometrial cancer surgery, cervical vulvar or vaginal cancer surgery in all stage, as indicated as indicated for surgery were included in the trial. The pre-assessment triage including respiratory symptoms, temperature, history of exposure or travel. Patients selected after this would be â??screenedâ?? with the RT-PCR test 48â?¯hours before the surgery and then isolated in their rooms with no visitors allowed.

Exclusion criteria

Exclusion criteria: Exclusion criteria were: minimally invasive surgery; emergency surgery due to any associated cause

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be assessment of Length of Hospital Stay (LOS) with the implementation of an enhanced recovery after surgery pathway. LOS was defined as the number of days from the day of surgery to discharge.Timepoint: 8 Months

Secondary

MeasureTime frame
ERAS protocol compliance, Incidence of pre-defined post-operative complications within 30 days after surgery, Readmission rate Time to commencement of adjuvant therapyTimepoint: 8Months

Countries

India

Contacts

Public ContactDr Kanika Batra Modi

Max Super Speciality Hospital(A Unit of Devki Devi Foundation),Saket

kanica.batra@gmail.com9873150686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026